World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
55
Citations
9923
World Ranking
3817
National Ranking
161

Michael P. Pender publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Michael P. Pender sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 252 publications — 52nd percentile

52% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Michael P. Pender D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Michael P. Pender sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 55 D-Index — 24th percentile

24% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Michael P. Pender is affiliated with the University of Queensland in Australia. Their research focuses primarily on multiple sclerosis and related immunological and neurological disorders.

The scientist has published extensively in the field of medicine, with 29 publications attributed to this main discipline. Their work spans several subfields including pathology and forensic medicine, immunology, oncology, neurology, and rheumatology.

Key topics in their research include:

  • Multiple Sclerosis Research Studies
  • Polyomavirus and related diseases
  • Peripheral Neuropathies and Disorders
  • Systemic Lupus Erythematosus Research
  • T-cell and Retrovirus Studies
  • Galectins and Cancer Biology
  • Olfactory and Sensory Function Studies

Their recent papers cover significant aspects of multiple sclerosis, including clinical improvements with T cell therapy and immune response factors:

  • "Sustained Clinical Improvement in a Subset of Patients With Progressive Multiple Sclerosis Treated With Epstein-Barr Virus-Specific T Cell Therapy," 2021, Frontiers in Neurology
  • "Correlation Between Anti-Myelin Proteolipid Protein (PLP) Antibodies and Disease Severity in Multiple Sclerosis Patients With PLP Response-Permissive HLA Types," 2020, Frontiers in Immunology
  • "High Prudent diet factor score predicts lower relapse hazard in early multiple sclerosis," 2020, Multiple Sclerosis Journal
  • "Epstein-Barr Virus in Multiple Sclerosis: Theory and Emerging Immunotherapies," 2021, Trends in Molecular Medicine
  • "Epstein-Barr virus-specific T cell therapy for progressive multiple sclerosis," 2020, JCI Insight

Their frequent coauthors include Bruce Taylor, Alan Coulthard, Anne-Louise Ponsonby, Jeannette Lechner-Scott, and Simon Broadley.

Publication venues where their work appears regularly include Multiple Sclerosis Journal, Brain Communications, Journal of Neurology, Frontiers in Neurology, and Frontiers in Immunology.

Best Publications

  • Genome-wide association study identifies new multiple sclerosis susceptibility loci on chromosomes 12 and 20

    Melanie Bahlo;David R Booth;Simon A Broadley;Matthew A Brown;Matthew A Brown

  • Sun exposure and vitamin D are independent risk factors for CNS demyelination

    Robyn Lucas;A.-L. Ponsonby;K. Dear;P.C. Valery

  • Infection of autoreactive B lymphocytes with EBV, causing chronic autoimmune diseases.

    Michael P. Pender

  • Apoptosis in the nervous system in experimental allergic encephalomyelitis

    M.P. Pender;K.B. Nguyen;P.A. McCombe;J.F.R. Kerr

  • Epstein–Barr Virus in Multiple Sclerosis: Theory and Emerging Immunotherapies

    Amit Bar-Or;Michael P. Pender;Rajiv Khanna;Lawrence Steinman

  • CD8+ T-Cell Deficiency, Epstein-Barr Virus Infection, Vitamin D Deficiency, and Steps to Autoimmunity: A Unifying Hypothesis

    Michael P. Pender

  • Immunology of multiple sclerosis.

    Michael P. Pender;Judith M. Greer

  • Immune dysregulation and self-reactivity in schizophrenia: do some cases of schizophrenia have an autoimmune basis?

    Amanda L Jones;Bryan J Mowry;Michael P Pender;Michael P Pender;Judith M Greer

  • The Essential Role of Epstein-Barr Virus in the Pathogenesis of Multiple Sclerosis

    Michael P. Pender

  • Variation in the vitamin D receptor gene is associated with multiple sclerosis in an Australian population

    Lotfi Tajouri;Micky Ovcaric;Rob Curtain;Matthew Peter Johnson

  • Increased circulating antiganglioside antibodies in primary and secondary progressive multiple sclerosis

    B. Tayyebeh Sadatipour;Judith M. Greer;Michael P. Pender

  • Apoptosis of inflammatory cells in immune control of the nervous system: Role of glia

    Michael P. Pender;Michael J. Rist

  • Epstein-Barr virus and multiple sclerosis: potential opportunities for immunotherapy.

    Michael P Pender;Michael P Pender;Michael P Pender;Scott R Burrows;Scott R Burrows

  • Epstein-Barr virus–specific T cell therapy for progressive multiple sclerosis

    Michael P. Pender;Michael P. Pender;Michael P. Pender;Peter A. Csurhes;Corey Smith;Nanette L. Douglas;Nanette L. Douglas

  • Epstein–Barr virus and multiple sclerosis

    Robyn Lucas;Ann Maree Hughes;Meav-Lang Lay;Anne-Louise Ponsonby

  • Offspring number, pregnancy, and risk of a first clinical demyelinating event The AusImmune Study

    A.-L. Ponsonby;Robyn Lucas;I.A. Van Der Mei;K. Dear

  • Genetically determined failure of activation-induced apoptosis of autoreactive T cells as a cause of multiple sclerosis

    Michael P Pender

  • Apoptosis of αβ T Lymphocytes in the Nervous System in Experimental Autoimmune Encephalomyelitis: Its Possible Implications for Recovery and Acquired Tolerance

    Michael P. Pender;Pamela A. McCombe;Gerald Yoong;Kim B. Nguyen

  • Defective T-cell control of Epstein-Barr virus infection in multiple sclerosis.

    Michael P Pender;Peter A Csurhes;Jacqueline M Burrows;Scott R Burrows

  • The occurrence of autoimmune diseases in patients with multiple sclerosis and their families.

    Robert D. Henderson;Christopher J. Bain;Michael P. Pender

  • Variation in the vitamin D receptor gene is associated with multiple sclerosis in an Austrlaian population

    Lotti Tajouri;Micky Ovcaric;Rob Curtain;Matthew P. Johnson

Frequent Co-Authors

Anne-Louise Ponsonby
Anne-Louise Ponsonby University of Melbourne
Terence Dwyer
Terence Dwyer University of Oxford
Scott R. Burrows
Scott R. Burrows QIMR Berghofer Medical Research Institute
Lyn R. Griffiths
Lyn R. Griffiths Queensland University of Technology
Anthony J. McMichael
Anthony J. McMichael Australian National University
Rajiv Khanna
Rajiv Khanna QIMR Berghofer Medical Research Institute
Michael F. Good
Michael F. Good Griffith University
Helmut Butzkueven
Helmut Butzkueven Monash University
Matthew A. Brown
Matthew A. Brown Guy's and St Thomas' NHS Foundation Trust
Jason M. Mackenzie
Jason M. Mackenzie University of Melbourne

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, exploring related healthcare fields can open up diverse career opportunities. Many professionals pivot to nursing roles, which complement immunological expertise, especially in clinical research and patient care. Online accelerated nursing programs for non nurses provide a fast track into the nursing profession without prior healthcare experience, making it a popular option for career changers.

If admission competitiveness is a concern, students might consider the easiest accelerated nursing programs to get into. These programs balance accessibility with quality education, allowing students to begin their nursing careers sooner. Likewise, LPN schools easy to get into offer a great entry point into nursing, often serving as a stepping stone to advanced practice.

For those aiming higher, nurse practitioner roles merge clinical skills with advanced patient management. Identifying what is the easiest NP program can help prospective students choose a pathway that suits their schedule and career goals without compromising on credentials. Overall, these related degrees enhance career flexibility and growth in fields connected to immunology.

Learn more about online accelerated nursing programs for non nurses, explore the easiest accelerated nursing programs to get into, discover lpn schools easy to get into, and find out what is the easiest np program to suit your educational needs.

Best Scientists Citing Michael P. Pender

Trending Scientists